Cargando…
Dlc1 interaction with non-muscle myosin heavy chain II-A (Myh9) and Rac1 activation
The Deleted in liver cancer 1 (Dlc1) gene codes for a Rho GTPase-activating protein that also acts as a tumour suppressor gene. Several studies have consistently found that overexpression leads to excessive cell elongation, cytoskeleton changes and subsequent cell death. However, none of these studi...
Autores principales: | Sabbir, Mohammad G., Dillon, Rachelle, Mowat, Michael R. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890663/ https://www.ncbi.nlm.nih.gov/pubmed/26977077 http://dx.doi.org/10.1242/bio.015859 |
Ejemplares similares
-
Myosin Heavy Chain 9 (MYH9)-Related Congenital Macrothrombocytopenia
por: Thurlapati, Aswani, et al.
Publicado: (2021) -
Myosin heavy chain-9-related disorders (MYH9-RD): a case report
por: Vassallo, Diana, et al.
Publicado: (2013) -
Effect of donor non-muscle myosin heavy chain (MYH9) gene polymorphisms on clinically relevant kidney allograft dysfunction
por: Pazik, Joanna, et al.
Publicado: (2020) -
The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity
por: Basak, Pratima, et al.
Publicado: (2015) -
The Role of Dlc1 Isoform 2 in K-Ras2(G12D) Induced Thymic Cancer
por: Sabbir, Mohammad Golam, et al.
Publicado: (2012)